MARJAN TABARESTANI: Open Payments
NPI 1275287534 · SPRINGFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,406 in 88 payments from 15 companies in 2025. Trend: 2023 $894 · 2024 $1,012 · 2025 $2,406
Food & beverage: $2,127Education: $279
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $521 |
| Lilly USA, LLC | 8 | $297 |
| LEO Pharma Inc. | 10 | $240 |
| Incyte Corporation | 7 | $229 |
| Janssen Biotech, Inc. | 6 | $225 |
| Regeneron Healthcare Solutions, Inc. | 7 | $190 |
| GENZYME CORPORATION | 5 | $178 |
| Arcutis Biotherapeutics, Inc. | 2 | $151 |
| Galderma Laboratories, L.P. | 6 | $98 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
Products named: DUPIXENT, SKYRIZI, ADBRY, OPZELURA, TREMFYA, RINVOQ, EBGLYSS, Zoryve.
Industry payments across NJ — which companies pay providers there.
